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Background: The function of vasodilator-stimulated phosphoprotein (VASP) in regulating actin polymerization during
airway smooth muscle contraction is unknown.
Results: VASP activity requires phosphorylation at Ser157, recruitment to the membrane, and interaction with activated
vinculin.
Conclusion: VASP regulates actin polymerization and contraction in smooth muscle by a unique mechanism.
Significance: The mechanism of VASP function is important for understanding actin dynamics in cells.
Vasodilator-stimulated phosphoprotein (VASP) can catalyze
actin polymerization by elongating actin filaments. The elonga-
tionmechanism involves VASP oligomerization and its binding
to profilin, a G-actin chaperone. Actin polymerization is
required for tension generationduring the contractionof airway
smooth muscle (ASM); however, the role of VASP in regulating
actin dynamics in ASM is not known. We stimulated ASM cells
and tissues with the contractile agonist acetylcholine (ACh) or
the adenylyl cyclase activator, forskolin (FSK), a dilatory agent.
ACh and FSK stimulated VASP Ser157 phosphorylation by dif-
ferent kinases. Inhibition of VASP Ser157 phosphorylation by
expression of the mutant VASP S157A in ASM tissues sup-
pressed VASP phosphorylation and membrane localization in
response to ACh, and also inhibited contraction and actin poly-
merization. ACh but not FSK triggered the formation of VASP-
VASP complexes as well as VASP-vinculin and VASP-profilin
complexes at membrane sites. VASP-VASP complex formation
and the interaction of VASP with vinculin and profilin were
inhibited by expression of the inactive vinculinmutant, vinculin
Y1065F, but VASP phosphorylation andmembrane localization
were unaffected. We conclude that VASP phosphorylation at
Ser157mediates its localization at themembrane, but that VASP
Ser157 phosphorylation and membrane localization are not suf-
ficient to activate its actin catalytic activity. The interaction of
VASP with activated vinculin at membrane adhesion sites is a
necessary prerequisite for VASP-mediated molecular processes
necessary for actin polymerization. Our results show that VASP
is a critical regulator of actin dynamics and tension generation
during the contractile activation of ASM.
Dynamic remodelling of the actin cytoskeleton is recognized
as an important step in the agonist-induced activation of con-
traction and tension development in airway smooth muscle
(ASM)2 and in other smooth muscle tissues (1). The regulation
of actin filament remodelling is a complex process involving the
coordinated activity of multiple proteins; but the molecular
mechanisms for actin remodelling and the processes by which
actin regulatory proteins are activated in response to contract-
ile and dilatory agents in smooth muscle tissues are poorly
understood. InASM, neuronalWiskott-Aldrich syndromepro-
tein (N-WASp) plays a critical role in the initiation of actin
polymerization during contractile stimulation by activating the
Arp2/3 complex (2). The Arp2/3 complex is believed to nucle-
ate the formation of new actin filaments that branch off the
sides of existing filaments (3). However, the importance of
other catalysts for actin polymerization in regulating the con-
traction of ASM has not been determined.
Members of the Ena/VASP family regulate cell motility and
shape in a wide variety of cell types (4, 5). Although a number of
molecular functions that affect actin dynamics have been
attributed to Ena/VASP proteins, there is extensive evidence
for their role as actin filament elongation factors, i.e. they bind
to the barbed (fast growing) ends of existing actin filaments and
promote filament lengthening (4, 6, 7). The mechanism for the
elongation of actin filaments by VASP is proposed to require
the assembly of VASP into tetrameric oligomers and the mem-
brane recruitment and anchoring of VASP to the scaffolding
proteins vinculin and zyxin at sites of actin filament assembly.
Filament elongation can then occur via the recruitment of pro-
filin-G actin complexes to bind to VASP tetramers, followed by
the transfer and assembly ofG-actinmonomers into the barbed
ends of the actin filaments that are also bound to VASP (8–10).
We evaluatedASM for evidence of aVASP-mediated process of
actin elongation during contractile and dilatory stimulation.
Ena/VASP proteins consist of 3 domains, N- and C-terminal
Ena/VASP homology 1 and 2 (EVH) domains and a central
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proline-rich region (4, 7). The EVH1 domain contains binding
sites for several focal adhesion scaffolding proteins including
vinculin; the proline-rich region contains binding sites for pro-
filin-actin, a primary source of actin monomers for actin fila-
ment polymerization; and the EVH2 domain contains binding
sites for filamentous (F)- and globular (G)-actin. The C-termi-
nal coiled-coil region within the EVH2 domain of VASP medi-
ates the assembly of VASP monomers into stable tetramers,
believed to be an essential step for VASP to function as an
elongation factor (4, 8, 11–15). Ena/VASP proteins are also
known substrates for both serine/threonine and tyrosine
kinases (16–18). The phosphorylation of VASP Ser157 has been
implicated in the cellular localization of VASP (17, 19). VASP
plays a role in the regulation of actin polymerization and con-
traction in aortic smooth muscle (20). VASP is expressed in
ASM tissues and undergoes phosphorylation at Ser157 during 
adrenergic stimulation (21, 22); but the function of VASP dur-
ing the contraction and relaxation of ASM is unknown.
Signaling events that regulate actin polymerization during
contractile stimulation of ASM are mediated by adhesome
complexes at integrin-ECM adhesion junctions (23). Vinculin,
a VASP ligand, plays an important structural role in these junc-
tions by binding to the integrin-binding proteins talin and-ac-
tinin as well as to actin filaments (24). Vinculin can assume a
closed conformation in which it does not bind to actin or talin,
and an open conformation in which its actin and talin binding
sites are exposed (25, 26). The contractile stimulation of ASM
tissues with ACh induces the recruitment of vinculin to mem-
brane adhesion complexes and its activation to an open ligand-
binding conformation (27, 28). Vinculin phosphorylation on
Tyr1065 is necessary for vinculin to sustain an activated confor-
mation in which it can bind to talin and actin filaments (27).
VASP has been shown to bind to the proline-rich hinge region
of vinculin at cell junctions (29–31); thus we hypothesized that
vinculin might play a role in the regulation of VASP-mediated
actin dynamics in ASM. To test this hypothesis, we evaluated
the molecular mechanisms by which contractile and dilatory
stimuli regulate the activity of VASP and its interaction with
vinculin in ASM.
Our results suggest that VASP functions as an actin elon-
gation factor at the ASM plasma membrane, and that the
interaction of VASP with activated vinculin is prerequisite to
this function. We conclude that VASP is an important catalyst
for actin polymerization during the contraction of ASM tissues.
EXPERIMENTAL PROCEDURES
Preparation of Smooth Muscle Tissues and Measurement of
Force—Mongrel dogs were euthanized in accordance with the
guidelines of the Institutional Animal Care andUseCommittee
(IACUC), Indiana University School of Medicine. The trachea
was immediately removed and immersed in physiological saline
solution at 22 °C. The solution was aerated with 95% O2, 5%
CO2 to maintain a pH of 7.4. Rectangular strips of tracheal
muscle 1 mm in diameter and 10 mm in length were dissected
after removal of the epithelium and connective tissue layer.
Each muscle strip was placed in physiological saline solution at
37 °C in a 25-ml organ bath and attached to a Grass force trans-
ducer for the measurement of force. At the beginning of each
experiment, muscle length was progressively increased until
the force of active contraction in response to a contractile stim-
ulus reached a maximum (optimal length).
Reagents and Antibodies—Antibodies used in these experi-
ments were: mouse monoclonal human VASP (BD Biosciences
Pharmingen), rabbit polyclonal human VASP (Cell Signaling),
mouse monoclonal human VASP phospho-Ser157 (Abcam),
mouse monoclonal human VASP phospho-Ser239 (Millipore);
rabbit polyclonal human VASP phospho-Ser239 (Cell Signal-
ing); rabbit polyclonal GFP (MBL); rabbit His tag (Cell Signal-
ing), rabbit polyclonal bovine myosin light chain, custommade
by BABCO (Richmond, CA); polyclonal vinculin (against
canine cardiac vinculin); mouse monoclonal human profilin1
(Abcam); rabbit polyclonal human profilin (Cytoskeleton);
mouse monoclonal human actin (Sigma); Alexa Fluor 488 and
546 (Invitrogen); and IRDye 800CW goat anti-mouse IgG and
IRDye 680LT goat anti-rabbit IgG (Li-Cor).
Reagents included the Duolink in situ proximity ligation kit
(PLA) and anti-mouse plus and anti-rabbit minus probes
(Olink Bioscience, Uppsala, Sweden), lysis and F-actin stabili-
zation buffers (Cytoskeleton), and protein kinase C inhibitor
bisindolylmaleimide I (BIM) (Sigma). Plasmid vectors used
included pcDNA3 EGFP full-length human VASP and VASP
S157A (alanine substituted at Ser157, His6 tagged) (17, 18),
pEGFP-vinculin full-length chicken vinculin (residues 1–1066)
(32), and non-phosphorylatable vinculin Y1065F (27).
Introduction of Plasmids into Tracheal Smooth Muscle
Tissues—Plasmids encoding full-length EGFP VASP and EGFP
VASP S157Awere introduced into the smoothmuscle strips by
the method of reversible permeabilization as previously
described (2, 33–36). Muscle tissues were attached to a metal
hooks and incubated successively in each of the following solu-
tions: Solution 1, which contained 10 mM EGTA, 5 mM
Na2ATP, 120mMKCl, 2mMMgCl2, and 20mMTES (at 4 °C, pH
7.1, 100% O2 for 120 min); solution 2, which contained 0.1 mM
EGTA, 5 mM Na2ATP, 120 mM KCl, 2 mM MgCl2, and 20 mM
TES and 10g/ml of plasmids (at 4 °C, pH 7.1, overnight); solu-
tion 3, which contained 0.1 mM EGTA, 5 mMNa2ATP, 120 mM
KCl, 10mMMgCl2, and 20mMTES (at 4 °C, pH7.1, 100%O2 for
30min); and solution 4, which contained 110mMNaCl, 3.4 mM
KCl, 0.8 mM MgSO4, 25.8 mM NaHCO3, 1.2 mM KH2PO4 (at
22 °C, pH 7.4, for 60min and aeratedwith 95%O2 and 5%CO2).
After 30 min in solution 4, CaCl2 was added gradually to reach
a final concentration of 2.4 mM. The plasmid-treated tissue
strips were then incubated at 37 °C for 2 days in DMEM con-
taining 5 mM Na2ATP, 100 units/ml of penicillin, 100 g/ml of
streptomycin, and 10g/ml of plasmids to allow for expression
of the recombinant proteins. Sham-treated tissues were sub-
jected to identical procedures except that no plasmids were
included in Solution 2. Tissues were then quickly frozen using
liquid N2-cooled tongs for biochemical analysis or dissociated
for cellular imaging studies.
Immunoblot and Immunoprecipitation—Frozen muscle tis-
sues were pulverized, and the proteins were extracted for elec-
trophoresis or immunoprecipitation as previously described (2,
28). For immunoprecipitation, the extracts were precleared at
4 °Cwith proteinA/GUltraLink Resin and incubatedwith anti-
bodies against the target protein.Western blotting of immuno-
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precipitates or muscle extracts was performed to quantitate
proteins. The proteins were visualized by ECL and digitally
quantified using a Bio-Rad ChemiDoc XRS detection system,
VASP phosphorylation at Ser157 was quantitated by probing
membranes simultaneously with mouse anti-phospho-Ser157
VASP Ab (Abcam) and polyclonal rabbit anti-VASP Ab (Cell
Signaling), and then using fluorescent probes to detect both
antibodies simultaneously using a Li-Cor Odyssey infrared
imaging system.
Myosin Light Chain Phosphorylation—Muscle strips were
rapidly frozen and then immersed in acetone containing 10%
(w/v) trichloroacetic acid and 10 mM DTT that was precooled
with dry ice. Strips were thawed in acetone/trichloroacetic
acid/DTT at room temperature and then washed 4 times with
acetone/DTT. Proteins were extracted for 2–3 h in 8 M urea, 20
mM Tris base, 22 mM glycine, and 10 mM DTT. Myosin light
chains (MLCs) were separated by glycerol-urea polyacrylamide
gel electrophoresis, transferred to nitrocellulose, and incubated
with polyclonal rabbit MLC 20 antibody (2, 37, 38). Unphos-
phorylated and phosphorylated bands ofMLCs were visualized
by ECL and quantified by densitometry. MLC phosphorylation
was calculated as the ratio of phosphorylated MLCs to total
MLCs for each sample.
Cell Dissociation and Analysis of Protein Localization—
Smooth muscle cells were enzymatically dissociated from tra-
cheal muscle strips, plated onto glass slides, and allowed to
adhere for 60 min as previously described (2, 35). After cells
were stimulated with ACh, FSK, or left unstimulated, cells were
then fixed and visualized for EGFP fluorescence or stained for
immunofluorescence analysis. The effects of stimulation with
ACh or FSK on the localization of proteins were evaluated in
freshly dissociated smooth muscle cells using a Zeiss LSM 510
confocal microscope. Images of smooth muscle cells were ana-
lyzed for regional differences in fluorescence intensity by quan-
tifying the pixel intensity with a series of cross-sectional line
scans along the entire length of each cell, excluding the nucleus
(2, 35). The ratio of pixel intensity between the cell periphery
and the cell interior was computed for each line scan by calcu-
lating the ratio of the average maximum pixel intensity at the
cell periphery to the averageminimumpixel intensity in the cell
interior. The ratios of pixel intensities between the cell periph-
ery and the cell interior for all line scans performed on a given
cell were averaged to obtain a single value for each cell.
In Situ Proximity Ligation Assay—In situ proximity ligation
assays were performed to detect interactions between VASP
and vinculin, VASP and profilin, VASP-VASP complexes, and
phospho-Ser157 VASP in dissociated cells. PLA provides a
method for the precise detection of protein-protein complexes
or interactions and protein modifications. Two primary anti-
bodies against the target proteins or protein epitopes are raised
in different species, and a pair of oligonucleotide-labeled sec-
ondary antibodies ( and  PLA probes) are targeted to each
pair of primary antibodies. The probes form circular DNA
strands only when they are bound in very close proximity (40
nm). These DNA circles serve as templates for localized rolling
circle amplification, generating a fluorescent signal (spot) that
enables individual interacting pairs of the target protein mole-
cules to be visualized. The PLA signal thus allows for the detec-
tion of a complex between two target proteins at a very high
resolution (39, 40).
Smooth muscle cells were fixed, permeabilized, and incu-
bated with a pair of primary antibodies of different species
against two target proteins followed by a pair of oligonucleotide-
labeled secondary antibodies (Duolink  and  PLA probes).
Mouse anti-VASP and rabbit anti-vinculin antibodies were
used to probe VASP-vinculin interactions, rabbit anti-VASP
and mouse anti-profilin antibodies were used to probe VASP-
profilin interactions, rabbit anti-VASP and mouse anti-VASP
phospho-Ser157 antibodies were used to detect VASP phospho-
Ser157, and mouse and rabbit phospho-Ser239 VASP antibodies
were used to detect VASP-VASP interactions. PLA probe
hybridization, ligation, amplification, and detection media
were administered according to the manufacturer’s instruc-
tions (Olink Bioscience). Cells from unstimulated and ACh- or
FSK-stimulated groups were analyzed for interactions by
counting PLA fluorescent spots using a Zeiss LSM510 confocal
microscope. Duolink ImageTool software was used to quanti-
tate PLA signals.
Analysis of F-actin/G-actin Ratio—The concentration of
F-actin and G-actin in smooth muscle tissues was measured
using an assay kit from Cytoskeleton Inc. Each of the smooth
muscle strips was homogenized in F-actin stabilization buffer.
The supernatants of protein extracts (G-actin fraction) were
collected after high speed centrifugation at 150,000  g for 60
min at 37 °C. The pellets were resuspended in ice-cold distilled
H2O plus 10 M cytochalasin D and then incubated on ice for
1 h to dissociate F-actin. The supernatant of the resuspended
pellets was collected after centrifugation at 4 °C. Equal volumes
of the first supernatant (G-actin) or second supernatant (F-ac-
tin) were subjected to analysis by immunoblot using anti-actin
antibody. The amount of F-actin and G-actin was determined
by densitometry and the ratio of F-actin to G-actin was used for
the analysis.
Statistics—Data are expressed as mean  S.E. Differences
between treatment groups were determined using paired or
unpaired two-tailed Student’s t test or analysis of variance. Dif-
ferenceswere considered statistically significantwhen p 0.05.
RESULTS
Stimulation with ACh, FSK, or Epinephrine Induces VASP
Phosphorylation at the Cell Membrane in ASM—VASP phos-
phorylation at Ser157 was measured in ASM tissues stimulated
with 104 or 105 M ACh for time periods up to 30 min (Fig.
1A). The shift in apparent molecular mass of VASP from 46 to
50 kDa by SDS-PAGE was used to analyze stoichiometric
changes in the phosphorylation of VASP at Ser157. We con-
firmed that the 50-kDa band was serine 157-phosphorylated
VASP by simultaneously probing each membrane using a site-
specific VASP phospho-Ser157 antibody (Fig. 1, A and B) (41).
Tissues were also stimulated with FSK for up to 20 min to eval-
uate VASP phosphorylation at Ser157 (Fig. 1, A and B). VASP
Ser157 phosphorylation increased significantly with both ACh
and FSK stimulation, approaching a maximum by 10 min (Fig.
1C).FSKinducedsignificantlyhigherlevelsofVASPSer157phos-
phorylation than ACh. Stimulation of muscles with the adre-
nergic hormone epinephrine affected VASP Ser157 phosphory-
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FIGURE 1.VASP Ser157 phosphorylation (VASP P-Ser157) increases during stimulationwith ACh, FSK, and epinephrine in ASM tissues. A, immunoblots
of VASP and phospho-Ser157 VASP from extracts of muscle tissues either unstimulated (US) or stimulated with 104 M ACh for time periods up to 30 min.
Phosphorylation of VASP on Ser157 was probed concurrently with VASP phospho-Ser157 and VASP antibodies. Probes were visualized using a Li-Cor Odyssey
imaging system. Ser157-phosphorylated VASP migrated concurrently with the 50-kDa VASP band (overlay). B, VASP Ser157 phosphorylation calculated from
VASP (green) and VASP phospho-Ser157 (red) immunoblots overlay very closely. In the VASP immunoblot, Ser157 phosphorylationwas calculated from the ratio
of the upper VASP 50-kDa band to total VASP (both 50- and 46-kDa bands). In the VASP phospho-Ser157 immunoblot, VASP Ser157 phosphorylation was
calculated from the phospho-Ser157 VASP band normalized to both VASP bands (46 and 50 kDa). For each stimulus agent, VASP Ser157 phosphorylation
determined from VASP phospho-Ser157 immunoblot was normalized to maximum VASP Ser157 phosphorylation. C,mean increases in VASP Ser157 phosphor-
ylation in response to stimulation with ACh (n  13–20) or FSK (n  14) at each time point. Both FSK and ACh cause significant increases in VASP Ser157
phosphorylation at all time points after stimulation; the increase in VASP Ser157 phosphorylation stimulated by FSK is significantly higher than that caused by
AChat all timepoints (p0.05).D and E, immunoblots andmean results for VASP Ser157 phosphorylation in tissues treatedor not treatedwith 10Mof the PKC
inhibitor BIM and stimulated with 105 M ACh or 106 M FSK. BIM causes significant inhibition of ACh stimulated but not FSK stimulated VASP Ser157
phosphorylation. *, significantly different from corresponding No BIM tissues (n  6). F, in situ PLA performed in freshly dissociated ASM cells using VASP
phospho-Ser157 and VASP antibodies to determine the localization of phospho-Ser157 VASP. Cells were stimulated with 104 M ACh, 106 M FSK, or left
unstimulated. Phospho-Ser157 VASP localizes at the ASM cell membrane in response to stimulation with either ACh or FSK. Each fluorescent spot indicates
Ser157-phosphorylated VASP. More spots are seen at the membrane of the ACh- or FSK-stimulated cells than of US cells. Results are representative of obser-
vations in 37 ACh-stimulated cells, 26 FSK-stimulated cells, and 33 US cells. G, localization of phospho-Ser157 VASP and total VASP in freshly dissociated ASM
cells stimulated with 104 M ACh, 106 M FSK, 104 M ACh and BIM, or US, and double stained for VASP and phospho-Ser157 VASP. VASP is found both at the
membrane and in the cytoplasmof ACh-stimulated, FSK-stimulated, andUS cells, but ismore concentrated at themembrane of the stimulated cells. Phospho-
Ser157 VASP is observed only on the cell membrane in US, ACh-, and FSK-stimulated cells. BIM treatment inhibits VASP recruitment to the membrane and
decreases ACh-induced VASP Ser157 phosphorylation, but does not affect the localization of Ser157-phosphorylated VASP on the membrane. Representative
results are from 55 US cells, 47 ACh-stimulated cells, 26 FSK-stimulated cells, and 15 ACh-stimulated cells treated with BIM.
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lation similarly to FSK, but with a somewhat more rapid time
course (Fig. 1, A and B).
The PKC inhibitor BIM (42) was used to determine whether
PKC is involved in the regulation of VASP Ser157 phosphoryla-
tion in response to ACh or FSK. Tracheal smooth muscle tis-
sues were treated with 10 M BIM and then stimulated with
ACh or FSK (Fig. 1, D and E). BIM treatment significantly sup-
pressed ACh-induced VASP Ser157 phosphorylation but it did
not affect VASP phosphorylation stimulated by FSK, indicating
that PKCmediatesVASP Ser157 phosphorylation in response to
stimulation with ACh but not FSK.
The cellular localization of phospho-Ser157 VASP was ana-
lyzed by PLA using probes against antibodies for phospho-
Ser157 VASP andVASP. Close proximity (40 nm) of the target
epitopes onVASP results in the generation of a fluorescent spot
indicating VASP phosphorylation. Phospho-Ser157 VASP was
observed on the membrane of unstimulated and ACh- or FSK-
stimulated cells; however, many more spots were observed in
cells stimulated with ACh or FSK than in unstimulated cells
(Fig. 1F).
Immunofluorescence was used to evaluate the localization of
phospho-Ser157 VASP and total VASP in freshly dissociated
cells (Fig. 1G). In both unstimulated cells and cells stimulated
with ACh or FSK, phospho-Ser157 VASP was only detected at
the cell membrane, whereas VASP was detected in both the
cytoplasm and at the cell membrane. The intensity of phospho-
Ser157 VASP fluorescence was much higher in ACh- or FSK-
stimulated cells than in unstimulated cells. Treatment with
BIM markedly reduced VASP phospho-Ser157 fluorescence in
ACh-stimulated cells and inhibited VASP localization to the
membrane (Fig. 1G).
Inhibition of VASP Ser157 Phosphorylation Inhibits ACh-in-
duced Smooth Muscle Contraction and Actin Polymerization,
but It Does Not Affect MLC Phosphorylation—His-EGFP VASP
S157A or His-EGFP VASP WT was expressed in ASM tissues
and force in response to 105 MAChmeasured after expression
(Fig. 2, A–C). VASP S157A does not undergo phosphorylation
at Ser157 due to the substitution of alanine for serine (Fig. 2C).
The expression of VASP S157A in ASM tissues significantly
depressed endogenous VASP Ser157 phosphorylation and
inhibited contractile force in response to 10 min stimulation
withACh (Fig. 2,A–E). Neither sham treatment nor expression
of VASPWT affected force or VASP Ser157 phosphorylation in
response to ACh.
The proportions of F-actin to G-actin were analyzed in
unstimulated and ACh-stimulated muscle tissues expressing
VASP S157A, VASP WT, or sham-treated tissues (Fig. 2F).
Expression of VASP S157A prevented the increase in the F- to
G-actin ratio in response to stimulation with ACh; whereas
expression of VASP WT or sham treatment had no significant
effect on actin polymerization in response to ACh. ACh stimu-
lation increased actin polymerization in tracheal muscle tis-
sues, whereas stimulation with FSK did not (Fig. 2G).
MLC phosphorylation was analyzed in unstimulated and
ACh-stimulatedmuscle tissues expressing VASP S157A, VASP
WT, or sham-treated tissues (Fig. 2, H and I). MLC phosphor-
ylation in response to ACh stimulation increased significantly
regardless of treatment and was not significantly different
among tissues expressing VASP WT, VASP S157A, or sham-
treated tissues.
ACh Stimulates the Recruitment of VASP and Vinculin to the
Membrane and the Formation of VASP-Vinculin Complexes;
FSK Stimulates the Membrane Recruitment of VASP but Not
Vinculin—Co-immunoprecipitation analysis was used to assess
the interaction of VASPwith vinculin in tissues stimulatedwith
ACh or FSK (Fig. 3A). Stimulation with ACh significantly
increased the amount of vinculin that co-precipitated with
VASP compared with unstimulated tissues (Fig. 3B). In con-
trast, stimulation with FSK did not significantly increase the
co-precipitation of vinculin with VASP.
The effects of ACh and FSK on the interaction of VASP and
vinculin were also evaluated using PLA in cells freshly dissoci-
ated fromASM tissues (Fig. 3,C andD). Significantlymore PLA
spots indicating VASP-vinculin complexes were observed in
ACh-stimulated cells than in FSK-stimulated or unstimulated
cells.
The colocalization of VASP and vinculin was evaluated by
double immunofluorescence staining. Smooth muscle cells
were freshly dissociated from tracheal smooth muscle tissues
and stimulated for 10 min with ACh or FSK or left unstimu-
lated. In unstimulated cells, both VASP and vinculin were dis-
tributed throughout the cell cytoplasm and at the membrane.
In cells stimulated with ACh, VASP and vinculin were co-local-
ized at the cell membrane, and little fluorescence was observed
in the cytoplasm for either protein. In cells stimulatedwith FSK,
VASP was localized almost entirely at the membrane, whereas
vinculin was distributed throughout the cytoplasm (Fig. 3E).
The effect of FSK and ACh on the distribution of VASP and
vinculin to themembrane versus the cytoplasmwas analyzed in
65 cells from 3 separate experiments (Fig. 3F). ACh stimulation
significantly increased the membrane localization of both
VASP and vinculin. In contrast, FSK stimulated the membrane
localization of VASP but not vinculin.
VASP Ser157 Phosphorylation Is Required for VASP Recruit-
ment to the Membrane and Its Interaction with Vinculin in
Membrane Protein Complexes—The role of VASP Ser157 phos-
phorylation in the cellular localization of VASP was evaluated
by analyzing the localization of EGFP VASP S157A and EGFP
VASP WT in dissociated cells stimulated with either ACh or
FSK (Fig. 4). Stimulation with either ACh or FSK caused the
recruitment of EGFP VASPWT to the membrane, but neither
AChnor FSK stimulated the recruitment of EGFPVASP S157A
to the membrane (Fig. 4, A and B). The amount of EGFP VASP
WT at the membrane was significantly higher in cells stimu-
lated with ACh or FSK than in unstimulated cells (Fig. 4B).
PLAwasused to evaluate the effect ofVASPSer157 phosphor-
ylation on the interaction of vinculin and VASP (Fig. 4, C and
D). In unstimulated freshly dissociated smooth muscle cells
expressingVASPWTorVASP S157A, very few PLA spots were
observed in the cell, indicating few protein complexes contain-
ing both VASP and vinculin. In cells expressing VASP WT,
stimulation with ACh caused a significant increase in the num-
ber of PLA spots at the cell membrane, indicating that ACh
stimulated the formation of VASP-vinculin protein complexes.
The expression of VASP S157A significantly inhibited the for-
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mation of VASP-vinculin protein complexes in response to
ACh.
Co-immunoprecipitation analysis was also used to evaluate
the interaction of vinculin and VASP in tissues expressing
VASP WT or VASP S157A. The amount of vinculin that co-
precipitated with VASP increased significantly in response to
ACh stimulation in sham-treated tissues and tissues expressing
VASPWT, but not in tissues expressing VASP S157A (Fig. 4, E
andF). Thus, the expression ofVASPS157A significantly inhib-
ited the formation of VASP-vinculin protein complexes in
response to ACh in both tissues and isolated dissociated cells,
demonstrating that the Ser157 phosphorylation of VASP and its
membrane localization are necessary for the interaction of
VASP with vinculin.
Vinculin Tyr1065 Phosphorylation and Activation Are
Required for the Formation of VASP-Vinculin Protein Com-
plexes at the Membrane—We previously demonstrated that
vinculin phosphorylation at Tyr1065 is required for vinculin to
maintain an open activated conformation (27). Smooth muscle
tissues were stimulated with FSK for 10 min or ACh for 5 min,
then vinculin Tyr1065 phosphorylation and VASP phosphoryla-
tion were analyzed by immunoblot (Fig. 5). Stimulation with
ACh, but not with FSK, induced vinculin Tyr1065 phosphoryla-
tion, indicating that vinculin undergoes activation in response
FIGURE 2. Expression of VASP S157A in ASM tissues inhibits ACh-stimulated contractile force and actin polymerization, but it does not affect MLC
phosphorylation. A, active stress in ASM tissues in response to stimulationwith 105 M ACh before and after expression of His-EGFP VASPWT, His-EGFP VASP
S157A, or sham transfection. B, expression of His-EGFP VASP S157A significantly depressed the force relative to sham-treated tissues, but expression of
His-EGFP VASP WT had no significant effect. ACh-stimulated force normalized to maximal force in sham-treated tissues. *, significantly different from sham-
treated tissues (n  9). C, immunoblot against the His epitope of VASP immunoprecipitates from ACh-stimulated or unstimulated (US) tissues expressing
His-EGFP VASPWT, His-EGFP VASP S157A, or sham treated. Expression of recombinant His-EGFP VASP and His-EGFP VASP S157Awas observed in transfected
tissues but not sham-treated tissues.D, immunoblot against VASP and VASP phospho-Ser157 from tissues transfected with His-EGFP VASPWT, His-EGFP VASP
S157A, or sham treated. E, expression of VASP S157A significantly inhibited endogenous VASP Ser157 phosphorylation in response to 105 M ACh stimulation
(n 11 for sham and VASP S157A, n 6 for VASP WT). *, significantly different from sham-treated tissues. F, actin polymerization was determined in tissues
expressingVASPS157A, VASPWT, or shamtreated. Actinpolymerization increases in response toACh in sham-treatedandVASPWT-treatedmuscle tissuesbut
not in tissues expressing VASP S157A. *, significantly different (n 11 for sham and VASP S157A, n 5 for VASPWT). G, actin polymerization was determined
in tissues stimulated with ACh, FSK, or US. Actin polymerization was significantly increased in response to ACh stimulation but not with FSK stimulation (n
4). H and I, MLC phosphorylation measured by urea gel electrophoresis in US or ACh-stimulated tissues expressing VASP S157A, VASP WT, or sham treated.
There were no significant differences in MLC phosphorylation among ACh-stimulated or US tissues subjected to different treatments (n 5).
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to ACh but not FSK (Fig. 5, A and B). In contrast VASP under-
goes phosphorylation at Ser157 in response to both ACh and
FSK (Figs. 5A and 1, A–C).
Wild type vinculin or the phosphorylation deficient vinculin
mutant Y1065F were expressed in ASM tissues to determine
whether vinculin activation is required for the formation of
VASP-vinculin complexes (Fig. 5, C–G). The interaction
between VASP and vinculin was evaluated in tissue extracts by
immunoprecipitation (Fig. 5, C and D). The amount of endog-
enous vinculin that co-precipitated with VASP increased sig-
nificantly in response toACh stimulation in sham-treatedmus-
cles and tissues expressing WT vinculin, but not in tissues
expressing vinculin Y1065F (Fig. 5,C andD). The expression of
vinculin Y1065F did not affect VASP Ser157 phosphorylation in
response toACh. Immunofluorescence analysis confirmed that
the expression of EGFP vinculin Y1065F also had no effect on
the localization of VASP phospho-Ser157 to the membrane
(Fig. 5E).
PLA assays were used to evaluate the interaction of vinculin
and VASP in freshly dissociated smooth muscle cells from tis-
sues expressing vinculin Y1065F or WT vinculin (Fig. 5, F and
G). Very few spots were detected in unstimulated cells. In cells
expressing WT vinculin, stimulation with ACh resulted in a
dramatic increase in the number of PLA spots at the cell mem-
brane, indicating that ACh stimulates formation of protein
complexes containing both VASP and vinculin. In the cells
expressing vinculin Y1065F, there were markedly fewer spots
indicating VASP-vinculin complexes, demonstrating that vin-
culin activation is required for the interaction of VASP with
vinculin in membrane complexes (Fig. 5, F and G).
StimulationwithAChbutNot FSKCausesVASP-VASPCom-
plex Formation at the Membrane—VASP can form tetrametric
homo-oligomers through VASP-VASP binding interactions at
its C terminus (11, 12). Although we could not probe specifi-
cally for VASP tetrameric homo-oligomers within the smooth
muscle cells and tissues, we used PLA to assess for protein com-
plexes containing multiple VASP molecules (VASP-VASP
complexes) (Fig. 6). The effect of stimulationwithACh andFSK
on VASP-VASP complex formation was investigated by using
VASP phospho-Ser239 as a target for both PLA and PLA
probes. VASP phospho-Ser239 was chosen as a target epitope
for the PLA probes because stimulation with ACh does not
cause a significant increase in phosphorylation at this site for
the first 10 min (Fig. 6, A and B). Thus, an increase in the num-
ber of PLA spots detected after 5–10min stimulation with ACh
should reflect more VASP-VASP interactions rather than an
increase in VASP Ser239 phosphorylation.
In cells stimulated for 10 min with ACh, VASP-VASP PLA
spots were clearly observed on the membrane, but spots were
barely evident in unstimulated cells (Fig. 6, C and D). In con-
trast, when PLA for VASP-VASP interactions was performed
on cells stimulated with FSK for 10 min, very few PLA spots
were observed (Fig. 6, C andD), even though FSK causes VASP
Ser239 phosphorylation to increase by more than 5-fold within
10 min (Fig. 6, A and B). Thus, stimulation with ACh induced
the formation of VASP-VASP complexes by membrane-local-
izedVASP proteins, whereas stimulationwith FSK did not. The
fact that FSK induces amuch higher level of VASP Ser239 phos-
phorylation than ACh confirms that an increase in the level of
VASP Ser239 phosphorylation by itself does not result in an
increase in the number of PLA spots.
The effect of VASP Ser157 phosphorylation on VASP-VASP
complex formation was evaluated by PLA in cells expressing
VASP S157A and VASP WT (Fig. 6, E and F). ACh-stimulated
cells expressing VASP S157A had significantly fewer VASP-
VASP PLA spots than cells expressing VASP WT, indicating
that the expression of VASP S157A inhibits VASP-VASP com-
plex formation in response to ACh. Thus, without Ser157 phos-
FIGURE 3. VASP forms complexes with vinculin at themembrane of ASM
cells in response to stimulation with ACh but not FSK. A, vinculin immu-
noprecipitates with VASP from extracts of ACh stimulated but not FSK stimu-
lated or US tissues. B, vinculin co-immunoprecipitation with VASP was signif-
icantly greater in extracts from ACh-stimulated than from FSK-stimulated or
US tissues. *, significantly different from US (n 9). C, interaction of vinculin
and VASP in freshly dissociated ASM cells was visualized by in situ PLA using
VASP and vinculin antibodies. Each fluorescent spot indicates complex
between vinculin and VASP. PLA spots are observed at the membrane of the
ACh-stimulated cells, whereas very few spots are observed in FSK-stimulated
or US cells. D, mean number of PLA spots was significantly higher in ACh-
stimulated smooth muscle cells than in FSK-stimulated or US cells. *, signifi-
cantly higher than US (n  27–35 cells). E, immunofluorescence images of
dissociated cells stimulatedwith ACh, FSK, or left unstimulated (US) and then
double stained for VASP (green) and vinculin (red). ACh increases the localiza-
tion of both VASP and vinculin at the cell membrane. FSK increases the local-
ization of VASP at the cell membrane, but has little effect on vinculin localiza-
tion. Merged images show colocalization of VASP and vinculin in yellow. F,
mean ratios of membrane to cytoplasmic pixel intensity for VASP and vincu-
lin. The ratio of membrane to cytoplasmic VASP localization is significantly
higher in ACh (n 28)- and FSK (n 15)-stimulated cells than in US cells (n
22). The membrane/cytoplasm ratio of vinculin localization is significantly
higher in ACh-stimulated cells than in US cells, but it is not significantly
increased in FSK-stimulated cells.
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phorylation, VASP does not form VASP-VASP complexes,
probably because it does not localize to the membrane.
The effect of vinculin activation on VASP-VASP complex
formation after stimulation with ACh was also evaluated by
PLA using cells expressing either WT vinculin or vinculin
Y1065F. There were significantly more PLA spots on the cell
membrane cells expressing WT vinculin than in cells
expressing vinculin Y1065F (Fig. 6, G and H). The results
demonstrate that vinculin activation is required for the for-
mation of VASP-VASP complexes at the cell membrane in
response to stimulation with ACh. Although FSK stimulates
VASP Ser157 phosphorylation, it does not stimulate vinculin
activation, and thus FSK does not induce VASP-VASP com-
plex formation.
Stimulation with ACh but Not FSK Increases the Interaction
of VASP and Profilin at theMembrane—Profilin binds to VASP
in its central proline-rich domain and is necessary for the trans-
fer of G-actin monomers to the barbed ends of actin filaments
by VASP (9). The effect of ACh and FSK on complex formation
between VASP and profilin was evaluated using co-immuno-
precipitation from tissue extracts and PLA in dissociated cells
(Fig. 7). Stimulation with ACh but not FSK significantly
increased the amount of profilin that co-immunoprecipitated
with VASP compared with unstimulated tissues (Fig. 7, A and
B). Significantly more PLA spots indicating VASP-profilin
interactions were detected in ACh-stimulated cells than in
FSK-stimulated or unstimulated cells (Fig. 7, C and D). These
results indicate that ACh but not FSK induces the binding of
profilin to VASP.
Vinculin Activation Is Required for the Formation of VASP-
Profilin Complexes—WT vinculin and the phosphorylation
deficient mutant vinculin Y1065F were expressed in ASM tis-
sues to determine whether vinculin activation is required for
the binding of profilin to VASP. The formation of complexes
FIGURE 4. Expression of EGFP VASP S157A inhibits the interaction of VASP and vinculin in response to ACh stimulation in ASM tissues. A, localization
of recombinant EGFP-VASP WT and EGFP VASP S157A in freshly dissociated ASM cells. Recombinant VASP was visualized in fixed cells by EGFP fluorescence.
EGFP VASPWT localizes to the cell membrane in response to ACh or FSK stimulation, but EGFP VASP S157A is distributed throughout the cytoplasm and does
not localize to the cell membrane after ACh or FSK stimulation. B,mean results for EGFP VASP WT and EGFP VASP S157A cellular localization in unstimulated
(US), ACh-, or FSK-stimulated smooth muscle cells. Values represent the ratio of membrane to cytoplasmic pixel intensity for each cell. *, indicates significant
difference fromUS cells (n 22–28).C, in situPLAwere performed to visualize the interaction of vinculinwith VASP in freshly dissociatedASMcells from tissues
expressingVASPWTor VASP S157A. Each fluorescent spot indicates a complex between vinculin andVASP.D,mean results for effects of VASPWT (n 46 cells)
and VASP S157A (n 30 cells) on the interaction of VASP and vinculin in US and ACh-stimulated cells. The expression of VASP S157A significantly reduces the
interaction of VASPwith vinculin in ACh-stimulated cells. *, significantly different. E, co-immunoprecipitation of vinculin after ACh stimulationwas detected in
VASP immunoprecipitates (IP) from tissues expressing VASPWT or sham treated, but not in tissues expressing VASP S157A. F, co-precipitation of vinculin with
VASP increases significantly in sham-treated tissues and tissues expressing VASP WT but not in tissues expressing VASP S157A (n 4).
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FIGURE 5. Vinculin activation is required for the ACh-induced interaction of VASP with vinculin. A, immunoblots of phospho-Tyr1065 vinculin and VASP
from 6 ASM tissues stimulated with 104 M ACh, 106 M FSK, or unstimulated (US). ACh stimulation increases vinculin phosphorylation at Tyr1065, but FSK has
no effect on the vinculin Tyr1065 phosphorylation. VASP phosphorylation at Ser157 increases with both ACh and FSK stimulation. B, vinculin Tyr1065 phosphor-
ylation increases significantly with ACh stimulation but not with FSK stimulation. *, significantly different from US (n 5). C, co-precipitation of vinculin was
observed in VASP immunoprecipitates (IP) after ACh stimulation of tissues expressing vinculin WT or sham-treated, but not in tissues expressing vinculin
Y1065F.D, co-precipitationof vinculinwithVASP increases significantly in sham-treated tissues and tissues expressingvinculinWTbutnot in tissues expressing
vinculin Y1065F. VASP Ser157 phosphorylation increased significantly in response to ACh in all 3 treatment groups. *, significantly different from US (n 4). E,
localization of endogenous Ser157-phosphorylated VASP in freshly dissociated ASM cells expressing EGFP vinculin Y1065F or EGFP WT vinculin. Cells were
double stained for VASP phospho-Ser157 and GFP to visualize recombinant vinculin. In cells expressing either vinculin WT or vinculin Y1065F, endogenous
Ser157-phosphorylated VASP was localized on the membrane. Both EGFP-vinculin and vinculin Y1065F localize to the cell membrane in response to ACh. F, in
situ PLA using VASP and vinculin antibodies were performed to visualize complexes between vinculin and VASP in freshly dissociated ASM cells from tissues
expressing vinculin WT or vinculin Y1065F. Each fluorescent spot indicates interaction between vinculin and VASP. The interaction of VASP with vinculin in
ACh-stimulated cells is inhibited in cells expressing vinculin Y1065F but not in cells expressing vinculin WT. G,mean number of PLA spots indicating vinculin-
VASP complexes for each treatment. Significantly more spots were observed in ACh-stimulated cells expressing vinculin WT (n 23) than in cells expressing
vinculin Y1065F (n 27). *, significant difference.
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FIGURE 6. Stimulation of ASM cells with ACh but not FSK induces VASP-VASP complex formation. VASP-VASP complex formation is inhibited by the
expression of VASP S157A or vinculin Y1065F. A, immunoblots of VASP Ser239 phosphorylation in tissue extracts in response to stimulation with ACh or FSK.
Ser239-phosphorylated VASP was detected in both bands of VASP using a site-specific Ser239 antibody. B, VASP Ser239 phosphorylation increased significantly
more in response to FSK (n 7) than in response to ACh (n 6). (Values are fold-increase over unstimulated (US).) *, significantly greater than US. C, in situ PLA
using VASP phospho-Ser239 mouse and rabbit antibodies to visualize VASP-VASP complex formation in freshly dissociated ASM cells. Each fluorescent spot
indicates a VASP-VASP interaction. VASP complex formation increases in smooth muscle cells in response to ACh stimulation but not in response to FSK
stimulation. D,mean results for VASP-VASP complex formation in response to FSK or ACh. *, significantly more PLA spots were observed at the membrane of
the ACh-stimulated cells (n 21) than in FSK-stimulated (n 29) or US cells (n 22). E, PLAwas performed to visualize VASP-VASP complex formation in cells
expressing VASPWTor VASP S157A. The expression of VASP S157Abut not VASPWT inhibits VASP-VASP complex formation in ACh-stimulated cells. F, *,mean
number of PLA spots was significantly higher in ACh-stimulated ASM cells expressing VASP WT (n 22) than in cells expressing VASP S157A (n 25). G, PLA
was performed to visualize VASP-VASP complex formation in cells expressing vinculin WT or vinculin Y1065F. The expression of vinculin Y1065F but not
vinculin WT inhibits VASP-VASP complex formation in ACh-stimulated cells. H, the total number of PLA spots was significantly higher in ACh-stimulated ASM
cells expressing vinculin WT than in cells expressing vinculin Y1065F. *, mean number of PLA spots was significantly higher in ACh-stimulated ASM cells
expressing vinculin WT (n 24) than in cells expressing vinculin Y1065F (n 27).
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between VASP and profilin was evaluated by co-immunopre-
cipitation and PLA (Fig. 8). The amount of profilin that co-
immunoprecipitated with VASP increased significantly in
response to ACh stimulation in sham-treated muscles and tis-
sues expressingWT vinculin, but not in tissues expressing vin-
culin Y1065F (Fig. 8, A and B). In cells expressingWT vinculin,
stimulation with ACh resulted in a significant increase in the
number of PLA spots along the cellmembrane, indicatingmore
interactions betweenVASP and profilin. In contrast, in the cells
expressing vinculin Y1065F, there were significantly fewer
spots at the membrane indicating VASP-profilin interactions.
The results demonstrate that vinculin activation is prerequisite
to the interaction of profilin with VASP at the membrane.
DISCUSSION
Our studies demonstrate that VASP is a critical regulator of
actin dynamics and tension generation during the contractile
stimulation of ASM (Fig. 2). Our results also indicate that the
interaction ofVASPwith activated vinculin atmembrane adhe-
sion sites is a necessary prerequisite for VASP-mediatedmolec-
ular processes that are required for actin polymerization (Figs.
5, 6, and 8). In ASM tissues, contractile stimulation triggered
FIGURE 7.ACh stimulation increases the interactionof profilinwithVASP
in ASM cells. A, immunoblots from tissues stimulated with ACh, FSK, or
unstimulated (US). Co-precipitation of profilin with VASP increases in
response to stimulation with ACh but not with FSK. B, *, significantly more
profilin co-precipitated with VASP from ACh-stimulated tissues than fromUS
or FSK-stimulated tissues (n 3). C, in situ PLA in freshly dissociated ASM cells
to visualize the formation of complexes between profilin and VASP. Each
fluorescent spot indicates a complex between profilin and VASP. D, *, signif-
icantly more PLA spots were observed in ACh-stimulated ASM cells (n 15)
than in FSK stimulated (n 18) or US cells (n 18). IP, immunoprecipitation.
FIGURE 8. Expression of vinculin Y1065F inhibits the VASP-profilin inter-
action. A, immunoblots from VASP immunoprecipitates (IP) from tissues
expressing vinculin WT, vinculin Y1065F, or sham-treated with or without
ACh stimulation. B, the amount of profilin that co-precipitated with VASP
during ACh stimulation increases significantly in sham-treated tissues and
tissues expressing vinculin WT but not in tissues expressing vinculin Y1065F
(n 5). *, significantly different fromUS.C,PLA in cells expressing vinculinWT
or vinculin Y1065F to visualize the formation of complexes between profilin
and VASP. Each fluorescent spot indicates a complex between profilin and
VASP. D, *, the total number of PLA spots was significantly higher in ACh-
stimulated cells expressing vinculin WT (n 21) than in cells expressing vin-
culin Y1065F (n 21).
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the formation of VASP-VASP complexes at the membrane and
also stimulated the interaction of profilin with VASP (Figs.
6–8). VASP oligomerization and its binding to profilin have
been shown to be necessary steps in the VASP-mediated actin
filament elongation process (7, 9); thus, our data are consistent
with a function for VASP as an actin elongation factor during
contractile stimulation.
We found that the stimulation of ASM with either ACh or
FSK induces the phosphorylation of VASP on Ser157 (Fig. 1).
The ACh-stimulated VASP Ser157 phosphorylation was medi-
ated by PKC. We evaluated the role of VASP Ser157 phosphor-
ylation on VASP activity by expressing the point mutant VASP
S157A in ASM tissues. VASP S157A expression inhibited
endogenous VASP phosphorylation on Ser157 and prevented
the localization of VASP to the membrane in response to stim-
ulation with either ACh or FSK (Figs. 2 and 4). When VASP
localization to themembrane was prevented, actin polymeriza-
tion and tension generation in response to contractile stimula-
tion (ACh)were inhibited, butMLCphosphorylationwas unaf-
fected (Figs. 2 and 4). We have previously found that in ASM,
the inhibition of actin polymerization does not affect the
increase in MLC phosphorylation in response to ACh, but that
tension generation is markedly reduced (2, 37). This suggests
that MLC phosphorylation and actin polymerization are inde-
pendently regulated and that both processes are necessary for
tension development (1).
Although FSK induced VASP Ser157 phosphorylation and
membrane localization, FSK did not stimulate actin polymeri-
zation (Fig. 2), the formation ofVASP-VASP complexes (Fig. 6),
or the interaction of profilin with VASP (Fig. 7). Thus, our
results suggest that VASP Ser157 phosphorylation and mem-
brane localization of VASP are necessary but not sufficient
steps to initiate the activity of VASP in catalyzing actin
polymerization.
Wenext evaluated the role of vinculin activation on the func-
tion of VASP in ASM tissues. We have previously shown that
ACh stimulation induces the recruitment of vinculin to mem-
brane adhesion complexes and vinculin activation (27, 28). In
the present study, we found that FSK does not stimulate the
recruitment of vinculin to the membrane (Fig. 3). Thus even
though FSK stimulates the phosphorylation of VASP at Ser157
and the recruitment of VASP to the membrane, the phosphor-
ylated VASP does not interact with vinculin.
We expressed the vinculin point mutant Y1065F in ASM
tissues to determine the role of vinculin activation on the reg-
ulation ofVASP activity. Using FRET technology,we previously
demonstrated that the phosphorylation of vinculin on Tyr1065
is necessary for vinculin to sustain its activated ligand-binding
conformation, and that themutant vinculin Y1065F localizes to
the membrane in a closed inactive conformation and inhibits
the activation of endogenous vinculin (Fig. 5E) (27). In the pres-
ent study, when vinculin activationwas inhibited by the expres-
sion of vinculin Y1065F, contractile stimulation induced the
phosphorylation of VASP on Ser157; but VASP did not interact
with vinculin (Fig. 5). Our observations suggest that even when
both vinculin and VASP are localized at the membrane, VASP
can only bind to vinculin when vinculin is in its open activated
conformation. The inhibition of vinculin activation by the
expression of vinculin Y1065F also prevented the formation of
VASP-VASP complexes and the interaction of VASP with pro-
filin (Figs. 6 and 8). These results suggest that vinculin activa-
tion and the binding of VASP to vinculin are necessary for
VASP-mediated actin polymerization. The activation of vincu-
lin may enable it to spatially and temporally coordinate the
activity of VASP with other actin filament assembly promoting
proteins.
The phosphorylation of VASP by cyclic nucleotide-depen-
dent PKA and PKG protein kinases is well documented in mul-
tiple cell types including platelets, endothelial cells, and vascu-
lar and ASM cells (17, 19–21). PKC-dependent VASP Ser157
phosphorylation has been reported in vascular smooth muscle
cells activated by serum stimulation (19, 43). Our findings are
consistent with observations in migrating vascular endothelial
cells that VASP phosphorylation on Ser157 provides a signal for
VASP localization to the membrane or the leading edge of the
cell (17, 19); however, these studies also reported that VASP
Ser157 phosphorylation had a minor impact on actin polymeri-
zation. In contrast, we find that stimulus induced actin poly-
merization in ASM tissues requires the Ser157 phosphorylation
of VASP (Fig. 2). However, our results suggest that this does not
result from a direct effect of VASP phosphorylation on its actin
catalytic activity; rather it results from the requirement that
VASP localize to the membrane and bind to activated vinculin
to initiate its actin catalytic function.We note that VASP Ser157
phosphorylation does not provide a reliable indicator of the
VASP activation with respect to actin dynamics.
VASP has been shown to bind to the proline-richmotif in the
hinge region of vinculin between its head and tail domains;
whereas the binding sites for vinculin on VASP are located
within its EVH1 domain (5, 29, 31, 44). Vinculin binding has
also been proposed tomediate the recruitment of VASP to focal
adhesion sites (29, 31). However, our studies demonstrate that
in ASM, VASP recruitment to the membrane occurs in the
absence of vinculin recruitment, and that the recruitment of
VASP does not depend on vinculin activation or the interaction
of VASP and vinculin. Our results are thus consistent with
VASP Ser157 phosphorylation as a primary event in the regula-
tion of VASP localization to adhesion junction complexes.
The assembly of VASP into tetrameric homo-oligomers is
critical for the VASP-mediated process of actin filament elon-
gation in vitro (4, 8, 13–15). Although VASP molecules self-
assemble into stable tetramers in vitro; there is no evidence
regarding the oligomerization state of VASP in living cells. We
used a PLA to probe for multimeric VASP-VASP complexes in
dissociated smooth muscle cells. Although PLA reports on
complex formation between individual VASP proteins, it is not
possible to confirm that the VASP protein complexes detected
by PLA are tetramers. Other multimeric forms of VASP could
be detected by PLA, as well as protein complexes that contain
multiple VASP proteins ormultimers bound in close proximity
to an intermediary protein such as F-actin. In vitro studies have
shown that VASP tetramers remain bound to the growing
barbed ends of F-actin filaments during the elongation process
(15). However, we observed few or no PLA spots in FSK-stim-
ulated cells or in unstimulated cells, and there were also very
few spots in ACh-stimulated cells treated with VASP S157A or
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vinculin Y1065F. These observations are consistent with the
possibility that VASP exists in a monomeric form in unstimu-
lated cells and assembles into tetramers atmembrane sites after
ACh stimulation, and that the assembly of VASP tetramers is
prerequisite to the functional role of VASP in actin dynamics.
PLAprovides a very high resolutionmethod for the detection
of protein-protein interactions and protein complexes in situ
(39, 40).We targeted the phospho-Ser239 epitope onVASP pro-
teins using two different species antibodies; thus the PLA signal
should reflect the interaction between at least twoVASPmono-
mers. The VASP Ser239 epitope was selected as a target because
VASP Ser239 phosphorylation does not increase above basal
levels within the first 10 min of ACh stimulation (Fig. 6B);
therefore an increase in the PLA signal in response to ACh
stimulationcannotreflectan increase inVASPSer239phosphor-
ylation. In addition, although stimulation of the cells with FSK
causes a 5–6-fold increase in VASP Ser239 phosphorylation
(Fig. 6,A and B); no PLA signal for VASP-VASP complexes was
detected in FSK-stimulated cells, which further confirms that
an increase in VASP Ser239 phosphorylation does not cause an
increase in the PLA signal (Fig. 6C). It remains possible that the
VASP-VASP PLA signal reflects the formation of VASP multi-
meric complexes with other proteins in response to stimulation
with ACh. However, if VASP is present primarily in tetrametric
form in unstimulated cells, FSK-treated cells, and in cells
treated with mutant VASP or vinculin, it is unclear why these
VASP tetramers do not generate a PLA signal.
Our previous studies demonstrated that the actin polymeri-
zation catalyst N-WASp is important for the activation of actin
polymerization by contractile agonists. We proposed that
N-WASp-mediated actin polymerization is likely to occur in
submembranous regions of the smooth muscle cell, and that
these actin filaments are therefore most likely distinct from the
actin filaments that participate in actomyosin cross-bridge
cycling (1). VASP is known to catalyze actin polymerization by
mechanisms that are different from those of N-WASp (4, 7). It
is therefore possible that VASP regulates actin polymerization
in a subset of actin filaments that are distinct from those regu-
lated by N-WASp, and that VASP-mediated actin polymeriza-
tion constitutes a separate pathway for actin remodelling in
ASM (2). However, our data show that VASP-protein interac-
tions that are necessary for its actin catalytic activity occur at
adhesome junctions at the plasma membrane and not in the
cytoplasm; VASP-mediated actin polymerization is most likely
also confined to submembranous pools of actin at the cell cor-
tex that are distinct from actin filaments in the contractile
apparatus in the interior of the cell. Although contractile fila-
ment actin may undergo remodelling during ASM contraction
and relaxation (45), mechanisms that might regulate the
remodelling of cytoplasmic contractile actin have not yet been
described.
Actin polymerization is recognized as an essential compo-
nent of the cellular response to agonist stimulation in many
smooth muscle cell types; however, its role in the cellular pro-
cesses that regulate the activation of signaling pathways and the
functional responses of the smooth muscle cells remain
unclear. Cortical actinmay serve a structural role to fortify link-
ages between the membrane junctional adhesome sites and
actin filaments within the contractile apparatus. In this capac-
ity, newly polymerized actin would serve to strengthen linkages
between membrane junctional proteins such as -actinin, vin-
culin, and talin and the actin filaments that interact with myo-
sin to mediate cell shortening and tension development. Regu-
lation of the connections between the contractile apparatus and
the cell membrane could also serve tomodify the orientation of
the contractile filaments to adapt the cell to shape changes
imposed by forces within its external environment. This could
be particularly important in ASM, which is continuously sub-
jected to changes in stress and strain during breathing (46).
However, the function of cortical actin dynamics may not be
entirely structural: cortical actin filaments may also provide a
lattice for the assembly of junctional complexes that transduce
signals from environmental stimuli to the interior of the cell.
Although the function and regulation of actin cytoskeletal
structures within smooth muscle remain to be established,
dynamic remodelling of the actin cytoskeletal lattice is likely to
serve multiple functions within the ASM cell.
REFERENCES
1. Gunst, S. J., and Zhang, W. (2008) Actin cytoskeletal dynamics in smooth
muscle: a new paradigm for the regulation of smooth muscle contraction.
Am. J. Physiol. Cell. Physiol. 295, C576-C587
2. Zhang, W., Wu, Y., Du, L., Tang, D. D., and Gunst, S. J. (2005) Activation
of the Arp2/3 complex by N-WASp is required for actin polymerization
and contraction in smooth muscle. Am. J. Physiol. Cell. Physiol. 288,
C1145-C1160
3. Higgs, H. N., and Pollard, T. D. (1999) Regulation of actin polymerization
by Arp2/3 complex and WASp/Scar proteins. J. Biol. Chem. 274,
32531–32534
4. Kwiatkowski, A. V., Gertler, F. B., and Loureiro, J. J. (2003) Function and
regulation of Ena/VASP proteins. Trends Cell Biol. 13, 386–392
5. Bear, J. E., andGertler, F. B. (2009) Ena/VASP: towards resolving a pointed
controversy at the barbed end. J. Cell Sci. 122, 1947–1953
6. Bear, J. E., Svitkina, T. M., Krause, M., Schafer, D. A., Loureiro, J. J.,
Strasser, G. A., Maly, I. V., Chaga, O. Y., Cooper, J. A., Borisy, G. G., and
Gertler, F. B. (2002) Antagonism between Ena/VASP proteins and actin
filament capping regulates fibroblast motility. Cell 109, 509–521
7. Dominguez, R. (2009) Actin filament nucleation and elongation factors:
structure-function relationships. Crit. Rev. Biochem. Mol. Biol. 44,
351–366
8. Breitsprecher, D., Kiesewetter, A. K., Linkner, J., Vinzenz, M., Stradal,
T. E., Small, J. V., Curth, U., Dickinson, R. B., and Faix, J. (2011)Molecular
mechanism of Ena/VASP-mediated actin-filament elongation. EMBO J.
30, 456–467
9. Ferron, F., Rebowski, G., Lee, S. H., and Dominguez, R. (2007) Structural
basis for the recruitment of profilin-actin complexes during filament elon-
gation by Ena/VASP. EMBO J. 26, 4597–4606
10. Haffner, C., Jarchau, T., Reinhard, M., Hoppe, J., Lohmann, S. M., and
Walter, U. (1995) Molecular cloning, structural analysis and functional
expression of the proline-rich focal adhesion and microfilament-associ-
ated protein VASP. EMBO J. 14, 19–27
11. Zimmermann, J., Labudde, D., Jarchau, T., Walter, U., Oschkinat, H., and
Ball, L. J. (2002) Relaxation, equilibrium oligomerization, and molecular
symmetry of the VASP(336–380) EVH2 tetramer. Biochemistry 41,
11143–11151
12. Bachmann, C., Fischer, L.,Walter, U., and Reinhard,M. (1999) The EVH2
domain of the vasodilator-stimulated phosphoproteinmediates tetramer-
ization, F-actin binding, and actin bundle formation. J. Biol. Chem. 274,
23549–23557
13. Kühnel, K., Jarchau, T., Wolf, E., Schlichting, I., Walter, U., Wittinghofer,
A., and Strelkov, S. V. (2004) The VASP tetramerization domain is a right-
handed coiled coil based on a 15-residue repeat. Proc. Natl. Acad. Sci.
Actin Polymerization by VASP Requires Activation of Vinculin
MAY 1, 2015•VOLUME 290•NUMBER 18 JOURNAL OF BIOLOGICAL CHEMISTRY 11415
U.S.A. 101, 17027–17032
14. Hansen, S. D., and Mullins, R. D. (2010) VASP is a processive actin poly-
merase that requires monomeric actin for barbed end association. J. Cell
Biol. 191, 571–584
15. Breitsprecher, D., Kiesewetter, A. K., Linkner, J., Urbanke, C., Resch, G. P.,
Small, J. V., and Faix, J. (2008) Clustering of VASP actively drives pro-
cessive, WH2 domain-mediated actin filament elongation. EMBO J. 27,
2943–2954
16. Gertler, F. B., Niebuhr, K., Reinhard, M., Wehland, J., and Soriano, P.
(1996) Mena, a relative of VASP and Drosophila Enabled, is implicated in
the control of microfilament dynamics. Cell 87, 227–239
17. Benz, P. M., Blume, C., Seifert, S., Wilhelm, S., Waschke, J., Schuh, K.,
Gertler, F., Münzel, T., and Renné, T. (2009) Differential VASP phosphor-
ylation controls remodeling of the actin cytoskeleton. J. Cell Sci. 122,
3954–3965
18. Blume, C., Benz, P.M.,Walter, U., Ha, J., Kemp, B. E., and Renné, T. (2007)
AMP-activated protein kinase impairs endothelial actin cytoskeleton as-
sembly by phosphorylating vasodilator-stimulated phosphoprotein.
J. Biol. Chem. 282, 4601–4612
19. Döppler, H., and Storz, P. (2013) Regulation of VASP by phosphorylation:
consequences for cell migration. Cell Adh. Migr. 7, 482–486
20. Kim, H. R., Graceffa, P., Ferron, F., Gallant, C., Boczkowska, M., Domin-
guez, R., and Morgan, K. G. (2010) Actin polymerization in differentiated
vascular smooth muscle cells requires vasodilator-stimulated phospho-
protein. Am. J. Physiol. Cell. Physiol. 298, C559-C571
21. Goncharova, E. A., Goncharov, D. A., Zhao, H., Penn, R. B., Krymskaya,
V. P., and Panettieri, R. A., Jr. (2012) 2-Adrenergic receptor agonists
modulate human airway smooth muscle cell migration via vasodilator-
stimulated phosphoprotein. Am. J. Respir. Cell Mol. Biol. 46, 48–54
22. Freyer, A. M., Billington, C. K., Penn, R. B., and Hall, I. P. (2004) Extracel-
lular matrix modulates 2-adrenergic receptor signaling in human airway
smooth muscle cells. Am. J. Respir. Cell Mol. Biol. 31, 440–445
23. Zhang, W., and Gunst, S. J. (2008) Interactions of airway smooth muscle
cells with their tissue matrix: implications for contraction. Proc. Am. Tho-
rac. Soc. 5, 32–39
24. Humphries, J. D., Wang, P., Streuli, C., Geiger, B., Humphries, M. J., and
Ballestrem, C. (2007) Vinculin controls focal adhesion formation by direct
interactions with talin and actin. J. Cell Biol. 179, 1043–1057
25. Ziegler,W.H., Liddington, R. C., and Critchley, D. R. (2006) The structure
and regulation of vinculin. Trends Cell Biol. 16, 453–460
26. Johnson, R. P., and Craig, S. W. (1994) An intramolecular association
between the head and tail domains of vinculin modulates talin binding.
J. Biol. Chem. 269, 12611–12619
27. Huang, Y., Day, R. N., and Gunst, S. J. (2014) Vinculin phosphorylation at
Tyr1065 regulates vinculin conformation and tension development in air-
way smooth muscle tissues. J. Biol. Chem. 289, 3677–3688
28. Huang, Y., Zhang, W., and Gunst, S. J. (2011) Activation of vinculin in-
duced by cholinergic stimulation regulates contraction of tracheal smooth
muscle tissue. J. Biol. Chem. 286, 3630–3644
29. Brindle, N. P., Holt, M. R., Davies, J. E., Price, C. J., and Critchley, D. R.
(1996) The focal-adhesion vasodilator-stimulated phosphoprotein
(VASP) binds to the proline-rich domain in vinculin. Biochem. J. 318,
753–757
30. Quinlan, M. P. (2004) Vinculin, VASP, and profilin are coordinately reg-
ulated during actin remodeling in epithelial cells, which requires de novo
protein synthesis and protein kinase signal transduction pathways. J. Cell.
Physiol. 200, 277–290
31. Hüttelmaier, S., Mayboroda, O., Harbeck, B., Jarchau, T., Jockusch, B. M.,
and Rüdiger, M. (1998) The interaction of the cell-contact proteins VASP
and vinculin is regulated by phosphatidylinositol-4,5-bisphosphate. Curr.
Biol. 8, 479–488
32. Cohen, D. M., Chen, H., Johnson, R. P., Choudhury, B., and Craig, S. W.
(2005) Two distinct head-tail interfaces cooperate to suppress activation
of vinculin by talin. J. Biol. Chem. 280, 17109–17117
33. Tang, D. D., Turner, C. E., and Gunst, S. J. (2003) Expression of non-
phosphorylatable paxillin mutants in canine tracheal smooth muscle in-
hibits tension development. J. Physiol. 553, 21–35
34. Zhang, W., Huang, Y., and Gunst, S. J. (2012) The small GTPase RhoA
regulates the contraction of smooth muscle tissues by catalyzing the as-
sembly of cytoskeletal signaling complexes at membrane adhesion sites.
J. Biol. Chem. 287, 33996–34008
35. Opazo Saez A., Zhang, W., Wu, Y., Turner, C. E., Tang, D. D., and Gunst,
S. J. (2004)Tension development during contractile stimulation of smooth
muscle requires recruitment of paxillin and vinculin to the membrane.
Am. J. Physiol. Cell Physiol 286, C433-C447
36. Zhang,W., andGunst, S. J. (2006) Dynamic association between-actinin
and -integrin regulates contraction of canine tracheal smooth muscle.
J. Physiol. 572, 659–676
37. Mehta, D., and Gunst, S. J. (1999) Actin polymerization stimulated by
contractile activation regulates force development in canine tracheal
smooth muscle. J. Physiol. 519, 829–840
38. Hathaway, D. R., and Haeberle, J. R. (1985) A radioimmunoblotting
method for measuring myosin light chain phosphorylation levels in
smooth muscle. Am. J. Physiol. 249, C345-C351
39. Söderberg, O., Gullberg, M., Jarvius, M., Ridderstråle, K., Leuchowius,
K. J., Jarvius, J., Wester, K., Hydbring, P., Bahram, F., Larsson, L. G., and
Landegren, U. (2006)Direct observation of individual endogenous protein
complexes in situ by proximity ligation. Nat. Methods 3, 995–1000
40. Söderberg, O., Leuchowius, K. J., Gullberg, M., Jarvius, M., Weibrecht, I.,
Larsson, L. G., and Landegren, U. (2008) Characterizing proteins and their
interactions in cells and tissues using the in situ proximity ligation assay.
Methods 45, 227–232
41. Butt, E., Abel, K., Krieger, M., Palm, D., Hoppe, V., Hoppe, J., andWalter,
U. (1994) cAMP- and cGMP-dependent protein kinase phosphorylation
sites of the focal adhesion vasodilator-stimulated phosphoprotein (VASP)
in vitro and in intact human platelets. J. Biol. Chem. 269, 14509–14517
42. Wentworth, J. K., Pula, G., and Poole, A.W. (2006)Vasodilator-stimulated
phosphoprotein (VASP) is phosphorylated on Ser157 by protein kinase
C-dependent and -independent mechanisms in thrombin-stimulated hu-
man platelets. Biochem. J. 393, 555–564
43. Chitaley, K., Chen, L., Galler, A., Walter, U., Daum, G., and Clowes, A.W.
(2004) Vasodilator-stimulated phosphoprotein is a substrate for protein
kinase C. FEBS Lett. 556, 211–215
44. Reinhard, M., Rüdiger, M., Jockusch, B. M., and Walter, U. (1996) VASP
interaction with vinculin: a recurring theme of interactions with proline-
rich motifs. FEBS Lett. 399, 103–107
45. Herrera, A. M., Martinez, E. C., and Seow, C. Y. (2004) Electron micro-
scopic study of actin polymerization in airway smooth muscle. Am. J.
Physiol. Lung Cell. Mol. Physiol. 286, L1161-L1168
46. Gunst, S. J., Tang, D. D., and Opazo Saez, A. (2003) Cytoskeletal remod-
eling of the airway smooth muscle cell: a mechanism for adaptation to
mechanical forces in the lung. Respir. Physiol. Neurobiol. 137, 151–168
Actin Polymerization by VASP Requires Activation of Vinculin
11416 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 290•NUMBER 18•MAY 1, 2015
